A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

CDY Insider Trading (Cellmid)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$19,929.86
Insider Selling (Last 12 Months): A$0.00

Cellmid Insider Trading History Chart

This chart shows the insider buying and selling history at Cellmid by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cellmid Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for CDY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
A One Stop Shop for Everything Futures Trading
Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!
Download your FREE Technical Analysis Trading Guide Today.

Cellmid Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2021Maria HalaszInsiderBuy362,361A$0.06A$19,929.86
4/1/2021Martin CrossInsiderIssued65,000A$0.08A$5,070.00
12/23/2020David KingInsiderBuy215,000A$0.11A$22,575.00
12/15/2020Dennis EckInsiderIssued465,437A$0.11A$49,801.76
6/22/2020Maria HalaszInsiderBuy152,789A$0.11A$17,265.16
6/18/2020Dennis EckInsiderIssued4,318,182A$0.22A$950,000.04
See Full Table
Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.

SEC Filings (Institutional Ownership Changes) for Cellmid (ASX:CDY)

Cellmid Limited, a life sciences company, researches, develops, and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers midkine, a driver and modulator of inflammatory diseases, including chronic inflammatory diseases and cancer; and focuses on blocking midkine, a protein for autoimmune disorders, chronic inflammation, osteoporosis, cardiovascular diseases, cancer, and neurodegenerative diseases. It also develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products under the evolis, evolis Professional, Lexilis Hybrid, Jo-Ju RED, and Lexilis BLACK brands. In addition, the company sells SARS-CoV-2 antibody kits and PCR tests. It markets its products through retailers and wholesalers, as well as through a direct-to-consumer e-commerce platform. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.
Read More on Cellmid

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Cellmid?

Cellmid's top insider shareholders include:
  1. David King (Insider)
  2. Dennis Eck (Insider)
  3. Maria Halasz (Insider)
  4. Martin Cross (Insider)
Learn More about top insider investors at Cellmid.
How Much Longer Will It Be Under $1?
The SEC and a group of high-powered lawyers have been hashing out a federally-regulated cryptocurrency.

Once ready, this crypto will become the 1st endorsed for use in the US.

I expect once the regulations are in place, this crypto's value will skyrocket.

Get into this crypto for under a dollar now.
>>>